TABLE 4.
Characteristic | Value |
---|---|
No. (%) of patients with the following indication to use ISA: | |
Prophylaxis | 5 (17.2) |
First-line therapy | 4 (13.8) |
Rescue treatment | 20 (69) |
No. (%) of patients with IFD | |
Possible | 10 (41.7) |
Probable | 9 (37.5) |
Proven | 5 (20.8) |
No. (%) of patients with the following IFD outcome: | |
Complete remission | 12 (50) |
Partial remission | 5 (20.8) |
Stable disease | 2 (8.3) |
Progression | 5 (20.8) |
No. (%) of patients with IFD-attributable mortality | 1 (3.4) |
% of patients with breakthrough infections | 0 |